Recent News

Dr. Todd Hutton, Medical Director of SoCal TMS, has long been recognized as a leader and noted researcher in the field of TMS.  Dr Hutton  was just published again, twice as lead author of two more research articles.

The most recent paper “The Anxiolytic and Antidepressant Effects of Transcranial Magnetic Stimulation in Patients With Anxious Depression” in the Journal of Clinical Psychiatry, shows that TMS has a clinically meaningful effect on patients who have both depression and anxiety. “Routine TMS delivered in diverse clinical settings results in marked anxiolytic and antidepressant effects in patients with anxious depression. The extent of improvement in anxiety and depression symptoms strongly covaries

The other paper, “Dosing Transcranial Magnetic Stimulation: Efficacy in Major Depressive Disorder as a function of number of treatment sessions“, shows that TMS is more effective as the number of treatment sessions increases.  “Data from this real-world, large database cohort, demonstrates a strong correlation between number of sessions in the TMS acute course and favorable MDD clinical outcomes. This increased benefit with increased treatment exposure also applies to individuals with incomplete benefit after 30 and 36 sessions. Extended treatment courses are associated with improved outcomes.”

You can click on this link to see a list of all of Dr Hutton’s research papers.

Dr. Todd Hutton, Medical Director of SoCal TMS was just published as co-author of the article “Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation” in the Journal of Affective Disorders.

The article does an excellent job of objectively quantifying the efficacy of TMS in treating patients suffering from depression.

You can click on the link below to view online, or download the article in PDF form here.

Dr. Todd Hutton, Medical Director of Southern California TMS Center, was a special guest on the popular podcast, “A Little Advice With Christine Little.” This podcast is hosted by actress and comedian, Christine Little, whose work has been featured on platforms such as FOX, Huffington Post, and Voyage L.A. In this interview podcast, Christine asks for a layman’s explanation of what the FDA-approved depression treatment, Transcranial Magnetic Stimulation (TMS) is, how it works, who it’s for, and how it continues to gain popularity with insurance companies.

Inside this interview with Dr. Hutton and Christine, you’ll learn about:

  • How TMS stimulates parts of the brain that is underactive (which is one of the factors contributing to depression)
  • Critical benefits of treating depression with TMS have over ECT (shock therapy) and standard antidepressants
  • The success rate of TMS and how it stacks up against other depression treatments
  • The role Brain Derived Neurotrophic Factor (BDNF) plays in a patient’s treatment process
  • How insurance companies look to cover this powerful depression treatment.


… and more. So please enjoy this podcast by clicking the play button below.

Hear how transcranial magnetic stimulation helped Greg fight clinical depression that led him to stay in bed for five years.




Matthew returns to The Doctors after seeking help to turn his life around after losing his legs and battling his heroin and opiate addictions.



As a special featured guest on the famed “The Dr. Drew Podcast”, Dr. Todd Hutton and Dr. Drew explore the ways that TMS helps treat depression, what makes it more desirable and safer than medicine, why it’s not more “mainstream,” and who TMS is recommended for. Get the inside scoop on TMS in this short <20 minute interview, click on the play button (below on the bottom left) and enjoy!



COVID-19 UPDATE : Our Commitment to Your Care & Mental HealthRead More